02 May 2023 | Tuesday | News
Michelle Jaeger, President & CEO
Mrs. Jaeger has been an instrumental part of DAS Health since joining the company as Chief Operating Officer in 2021 and subsequently being promoted to President. With over 20 years of experience in healthcare and technology, Jaeger has brought a wealth of knowledge to DAS Health, helping to drive organic enterprise sales, complete and integrate multiple acquisitions, and develop effective strategies that have led to increased revenue and market share. Her previous experience in various leadership roles provides her with unique expertise that will be a crucial part in continuing DAS Health’s impressive growth trajectory.
"I am thrilled to be taking on this new role and am grateful to the DAS Health team for their support and trust in me," said Jaeger. "Our company has achieved great success in recent years, and I am committed to building on that momentum and driving continued growth for DAS Health and our clients."
As CEO, Jaeger will continue to oversee the company's operations and strategic initiatives, working closely with the leadership team to further advance DAS Health's mission of providing innovative and effective healthcare solutions to clients across the United States.
"To say that I am excited to have Michelle officially take the helm of DAS Health is an understatement," said David Schlaifer, who will step into the role of Executive Chairman. "It is rare that you can find someone who you know will not only protect a legacy, but substantially improve upon it. Michelle is that rare individual. Her leadership, expertise, and commitment to our team and clients make her the perfect fit for this role, and I look forward to seeing the company thrive under her leadership."
© 2024 Biopharma Boardroom. All Rights Reserved.